Edition:
United States

Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

115.71USD
22 May 2017
Change (% chg)

$-1.22 (-1.04%)
Prev Close
$116.93
Open
$116.50
Day's High
$116.69
Day's Low
$113.63
Volume
5,685,232
Avg. Vol
3,783,658
52-wk High
$127.64
52-wk Low
$94.42

All Insider Trades
Trading Date Name Title Type Shares Traded Price
1 Dec 2016

Fouse (Jacqualyn A)

President Buy 5,000 $0.00
1 Dec 2016

Pehl (Michael F)

Officer Sell 892 $117.63
1 Dec 2016

Alles (Mark J)

Chief Executive Officer Buy 6,560 $0.00
1 Dec 2016

Smith Scott Andrew

Officer Sell 1,944 $117.63
1 Dec 2016

Pehl (Michael F)

Officer Buy 1,880 $0.00
1 Dec 2016

Fouse (Jacqualyn A)

President Sell 2,352 $117.63
21 Nov 2016

Vessey (Rupert)

Officer Sell 2,500 $123.18
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,668 $49.48
9 Nov 2016

Pehl (Michael F)

Officer Buy 625 $103.10
9 Nov 2016

Pehl (Michael F)

Officer Buy 625 $118.57
9 Nov 2016

Pehl (Michael F)

Officer Buy 781 $109.90
9 Nov 2016

Pehl (Michael F)

Officer Buy 781 $114.08
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,874 $74.30
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,876 $78.12
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,250 $117.18
9 Nov 2016

Pehl (Michael F)

Officer Sell 20,424 $121.03
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,668 $36.47
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,876 $71.33
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,668 $34.70
9 Nov 2016

Pehl (Michael F)

Officer Buy 938 $36.36
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,250 $87.64
9 Nov 2016

Pehl (Michael F)

Officer Sell 1,628 $121.15
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,876 $59.24
9 Nov 2016

Pehl (Michael F)

Officer Buy 1,668 $36.68
8 Nov 2016

Hugin (Robert J)

Officer and Director Sell 100,000 $120.00

Institutional Holders

% Shares Owned: 80.49%
# of Holders: 1,857
Total Shares Held: 628,469,194
3 Mo. Net Change: 4,171,498
# New Positions: 131
# Closed Positions: 72
# Increased Positions: 747
# Reduced Positions: 683
# Net Buyers: 64

Officers & Directors

Name Age Since Current Position

Robert Hugin

62 2016 Executive Chairman of the Board

Scott Smith

55 2017 President, Chief Operating Officer

Mark Alles

58 2016 Chief Executive Officer, Director

Peter Kellogg

61 2014 Chief Financial Officer, Executive Vice President

Terrie Curran

48 2017 President, Global Inflammation & Immunology Franchise

Michael Pehl

52 2016 President, Hematology & Oncology

Rupert Vessey

52 2016 President - Research and Early Development

Gerald Masoudi

49 Executive Vice President, General Counsel and Corporate Secretary

Michael Casey

71 2007 Lead Independent Director

Michael Bonney

58 2015 Director

Jacqualyn Fouse

56 2017 Director

Julia Haller

62 2015 Director

Richard Barker

68 2012 Independent Director

Carrie Cox

59 2009 Independent Director

Michael Friedman

73 2011 Independent Director

Gilla Kaplan

70 1998 Independent Director

James Loughlin

74 2007 Independent Director

Ernest Mario

79 2007 Independent Director